%0 Journal Article
%T FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD©\L1
%A Amy E. McKee
%A Huanyu Chen
%A Janaki Veeraraghavan
%A Kirsten B. Goldberg
%A Kun He
%A Lola Fashoyin©\Aje
%A Martha Donoghue
%A Patricia Keegan
%A Richard Pazdur
%J Archive of "The Oncologist".
%D 2019
%R 10.1634/theoncologist.2018-0221
%K GEJ adenocarcinoma
%K Accelerated approval
%K PD©\L1
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324629/